ADMA Biologics
ADMA
ADMA
90 hedge funds and large institutions have $67.7M invested in ADMA Biologics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 32
80% less call options, than puts
Call options by funds: $712K | Put options by funds: $3.49M
Holders
90
Holding in Top 10
–
Calls
$712K
Puts
$3.49M
Top Buyers
| 1 | +$2.34M | |
| 2 | +$1.6M | |
| 3 | +$919K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$498K |
| 5 |
E
Ergoteles
New York
|
+$479K |
Top Sellers
| 1 | -$5.72M | |
| 2 | -$1.37M | |
| 3 | -$1.32M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$956K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$795K |